French drug trial 'accident' leaves one person brain-dead, five seriously ill

[Judi Lynn]

Source: ABC News (Australia)

French drug trial 'accident' leaves one person brain-dead, five seriously ill

Updated about 4 hours ago

One person has been left brain-dead and three others face irreversible brain damage after taking part in a drugs trial in France.

Six volunteers were hospitalised last week after taking part in the phase one trial of a new medication meant to treat mood disorders such as anxiety, developed by Portuguese pharmaceutical company Bial.

Health Minister Marisol Touraine said the men, aged between 28 and 49, were part of a group of 90 people who had taken the drug, while about 30 others had received a placebo.

All were given varying doses and the six men hospitalised were the group who were taking the drug "regularly".



Read more: http://www.abc.net.au/news/2016-01-15/one-person-brain-dead-following-french-drug-trial/7092558

[uppityperson]

1. 3 days on it does this? :(

[Marty McGraw]

2. Potent Dope

( '-')

[pansypoo53219]

3. better living thru chemistry!!!!

[safeinOhio]

4. Pills for anxiety

seem to always have terrible side effects. Exercise and cognitive strategies to deal with the anxiety are more effective and safer.

[gvstn]

10. But cognitive strategies requiring a therapist are not profitable.

Better to find a pill with a 10,000% markup. That's the way big medicine rolls.

[bananas]

5. The drug acted on endocannibinoids

She said the drug acted on natural receptors found in the body known as endocannibinoids which regulate mood and appetite, and not the compound found in the cannabis plant.

Just legalize the plant already, stop trying to find a patentable synthetic.

These patients are just more victims in the war on drugs.

[Geronimoe]

6. So it worked?

It sounds like they don't have mood disorder any more.

[marble falls]

7. Seriously. Shame on you.

[proverbialwisdom]

8. Biotrial's Clinical Pharmacology Unit is operating in Newark, NJ (from NYT link).

http://motherboard.vice.com/read/drug-trial-that-left-one-man-brain-dead-has-nothing-to-do-with-cannabis
http://www.nytimes.com/2016/01/16/world/europe/french-drug-trial-hospitalization.html

http://www.biotrial.com

SEE: Volunteer and participate in our clinical trials in Newark, NJ
SEE: A Niche Provider with Strategic Locations

NYT link oddly out-of-date except maybe for showing how connected the firm is to Rutgers/NJMS (public/private partnership):

http://www.biotrial.com/news/biotrial-celebrates-the-mid-point-in-construction-of-their-us-headquarters.html

Biotrial Celebrates the Mid-Point in Construction of their US Headquarters
November 25th, 2014 – Newark, NJ, USA

On Wednesday, November 19th, 2014, Biotrial held a “Half Way There” event in Newark to celebrate the advancement of the construction of their Clinical Pharmacology Unit. The future site, located in the heart of the University Heights Science Park, attached to Rutgers/NJMS and the University Hospital, is the perfect location for performing Early Development Clinical Studies. Comprised of 60 000 sq. ft., this modern, state-of-the-art building will be completed and ready for occupation mid-2015, with the first Phase I and Bioequivalence Studies to be performed before the end of the year.

Attending the event were key figures from the surrounding institutions, financial partners, representatives from Newark City Business Development and the State of NJ, in addition to important members of the construction project team. Speakers included Dr. Joel Bloom, President, NJIT & Chairman, UHSP Board of Trustees, Dr. William Gause, Sr. Associate Dean, Research, Rutgers/NJMS, Dr. Debi Lazzarino, Assistant Dean for Research, Rutgers/NJMS, John Kinghorn, Investment Manager, Prudential Financial, James Crispino, President, Francis Cauffman and Paul Natoli, President, Joseph A. Natoli Construction.

The event was held at the International Center for Public Health, Biotrial’s neighbour who is directly adjacent to the future site. The Phase I Clinic, which will be located at 130 Norfolk St., has the Norfolk Street Station Light Rail stop at the north end of the property. Biotrial chose the site for its ease of access via public transportation as well as its close proximity to major roadways and Newark’s International Airport. These, in addition to the proximity to the University Hospital, Rutgers and NJMS, make the location an ideal one for the Clinical Research Facility.

<>

[muriel_volestrangler]

9. France drug trial: Brain-dead man dies in hospital

A man left brain-dead after an experimental drug trial in France has died, local media report.

He was one of six people being treated in hospital in the city of Rennes.

The other five remain in a stable condition, the hospital said, four had "neurological problems", the fifth had no symptoms.

http://www.bbc.co.uk/news/world-europe-35337671

[LisaL]

11. He was described as being brain dead, which is the same as being dead.

So obviously there was no hope for his recovery. One doesn't come back from the dead.